Here are the 10-Q quarterly reports from Reliance Global Group, Inc. Series A Warrants (EZRAW) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow EZRAW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EZRAW filings page.
Reliance Global Group (Nasdaq: EZRA) reported a first‑quarter 2026 net loss of $1.47 million, narrowing from $1.74 million a year earlier, as it continued reshaping its portfolio and cost structure. Commission revenue declined about 10% to $3.83 million, mainly due to selling several agencies in 2025, partly offset by roughly 11% organic growth in remaining businesses.
Operating expenses fell to $5.07 million from $5.64 million, but non‑GAAP AEBITDA turned to a loss of $0.43 million from a positive $0.15 million, largely because equity‑based compensation was much lower in 2026 and therefore added back less. Cash and restricted cash rose to $3.24 million with working capital of about $2.60 million and stockholders’ equity of $7.42 million.
The company invested about $0.50 million in Enquantum, taking a roughly 23.8% stake and recording an equity‑method loss of about $26,000. It also completed a public offering providing roughly $2.0 million in gross proceeds and realized about $0.84 million from warrant exercises, while modestly using its at‑the‑market program.
Subsequent to quarter‑end, Reliance formed majority‑owned LifeSci Global Group to invest about $2.0 million in Innervate Radiopharmaceuticals and expanded its equity line of credit to $50.0 million, with about $49.1 million remaining. The board approved a 1‑for‑40 reverse stock split to help regain compliance with Nasdaq’s $1.00 minimum bid price requirement, highlighting listing risk alongside the company’s push into technology and life sciences through its EZRA International Group and Scale51 strategy.